Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alexander Mitchell’s Scopus Asset Management Increased Its Stake in $VTNC

Alexander Mitchell’s Scopus Asset Management increased its position in Vitran Corp Inc. (VTNC) to 932,594 shares, or 5.7% passive stake ownership, according to its 13G filing on October 28th. As reported in the second quarter, Scopus Asset Management previously had 245,878 shares in its position. VTNC has a poor path in the third quarter and has dropped by more than 60% year to date. Now the stock is bottoming up from its 2-year low, and is trading at $5.08.


In the second quarter, four hedge funds in our tracking list owned VTNC inn their portfolios. Ken Brodkowitz And Mike Vermut’s Newland Capital took more shares than Alexander Mitchell’s Scopus Asset Management, with about 1.3 million shares in its position.

Alexander Mitchell’s Scopus Asset Management is a New York-based hedge fund, It’s a private company categorized under Business Management. The firm has a $2.68 billion portfolio, and mainly invests in Services and Consumer Goods sector.

Vitran Corporation Inc. engages in freight surface transportation and related supply chain services in Canada and the United States. The company has Less-than-truckload services (LTL) segment and Supply Chain Operation (SCO) segment under operation. The company was founded in 1981 and is based in Toronto, Canada.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!